GenoLogics has launched Proteus-Analytics, a proteomics software package that integrates the company’s Proteus lab and data-management system with Proteome Software’s ScaffoldBatch software for protein identification, visualization, and validation.
The National Center for Biotechnology Information said this week that it will release a new default interface for NCBI Blast on April 16. The new interface is currently available as a beta release here. The previous interface will remain available until May 14, NCBI said.
NCBI said the new Blast pages “have been tested and produce correct results” with several client programs that support URLAPI, a protocol that scripts use to run Blast searches over HTTP, including the BioPerl RemoteBlast module, the NCBI demo script, and “various scripts used in-house at NCBI.”
Pesca 2.0, a Cytoscape plug-in, is available here from the University of Verona. The software is able to find all the shortest paths between two nodes in a network, according to its developers.
Acumenta has released Literature Lab version 1.1, a literature analysis for research scientists in biotechnology and pharmaceutical companies “who occasionally or regularly do literature review in carrying out genomic/proteomic research,” the company said in a statement. The software automatically interrogates more than 8.5 million scientific journal abstracts on PubMed and uses “a novel analysis method” to evaluate associations between a scientist’s area of interest and critical biological functions and identify “the most important terms” related to a scientist’s work, the company said.
ChemZoo has released ChemSpider, a web-based service for chemical structure and substructure searching. The ChemSpider database indexes more than 10 million compounds, including the PubChem collection and third-party data.
Strand Life Sciences has launched Sarchitect, a structure-activity relationship modeling platform. The company said that it has signed Gilead Sciences as its first customer for the product, which is available in two versions: Designer, for use by computational scientists; and Miner, for in silico lead optimization by medicinal chemists.
Sarchitect Designer is based on machine-learning algorithms and workflows that guide users through building models on their data, while Sarchitect Miner allows medicinal chemists to use models to profile molecules across target properties.